# Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)

> **NCT02448524** · PHASE3 · UNKNOWN · sponsor: **Micell Technologies** · enrollment: 428 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** MiStent
- **DEVICE:** TIVOLI

## Key facts

- **NCT ID:** NCT02448524
- **Lead sponsor:** Micell Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2018-11-30
- **Final completion:** 2022-11
- **Target enrollment:** 428 (ACTUAL)
- **Last updated:** 2020-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02448524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02448524, "Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02448524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*